French Word of the Day: Esperluette
Why do I need to know Esperluette?
Because it's the French for a very common symbol in language that isn't
l'arobase*
.
What does it mean?
Esperluette
– roughly pronounced ess-per-loo-ette – is the French word for the ampersand or 'and' symbol. It's also sometimes known as '
et commercial
', because so many businesses have it in their name.
It describes the & symbol, which is a typographical combination of the letters E and T. The symbol dates back to Roman times - its first known use is on a papyrus from 45CE. In fact, the French for 'and' is taken from the Latin - et.
Sadly, contrary to popular belief, ampersand was not named after the French physicist André-Marie Ampère. It is not 'Ampère's and', no matter how much we may want it to be.
Advertisement
The origins of the French word are harder to pin down. It could a corruption of the Occitan es per lo et (pronounced ess per loo ett) - which, in French becomes 'C'est pour le « et »' … or, 'it's for the 'and''.
Similarly, it could come from Picardy, as a corruption of perluète - when the symbol & was more commonly included in the alphabet, after the letter Z.
Interestingly, the symbol has evolved over the centuries. But the first recognisably modern form was developed by Claude Garamond - yes, that Garamond, of font fame - in the 15th century for use in printing presses.
Use it like this
Le 'et' entre le V et le B est une esperluette
- the 'and' between the V and the B is an ampersand
* If you've ever given out your email address in French you will know
l'arobase
(pronounced lar-oh-baz), it's the French for the @ symbol
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
an hour ago
- Euronews
L'Oréal acquires a majority stake in British skincare brand Medik8
L'Oréal has acquired a majority stake in the UK's Medik8 as it seeks to expand its position in the skincare market, the French beauty giant confirmed on Monday. As part of the deal, private equity firm Inflexion will remain a minority shareholder, and the current management committee will also stay in their roles. The cost of the stake is officially undisclosed, although the Financial Times reported last week that the potential deal was worth around €1bn. L'Oréal's share price was roughly unchanged on the news. 'We are delighted to welcome Medik8 to the L'Oréal family,' said Cyril Chapuy, President of L'Oréal LUXE. 'As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' he added. L'Oréal has been seeking to capitalise on the boom in science-driven skincare, partly driven by social media influencers. Brands already under its 'Dermatological Beauty Division' include La Roche-Posay, Cerave, Vichy, Skinceuticals, and Skinbetter Science. This unit brought in over €7bn in revenue in 2024, representing an almost 10% year-on-year rise, making it L'Oréal's fastest-growing division. Seeking to expand its portfolio, L'Oréal bought soap maker Aesop in 2023, and Korean beauty brand Dr.G in December. Last year, L'Oréal also acquired a 10% stake in skincare firm Galderma, as well as acquiring the beauty licence for Miu Miu. At the time of the Galderma deal, the French firm said it was 'increasingly investing in a more holistic approach, spanning the entire beauty routine' — thereby 'anticipating and intercepting the signs of skin ageing'. Medik8, founded in 2009, specialises in anti-ageing treatments and was bought by UK-based private equity firm Inflexion in 2021. Media conglomerate Warner Bros. Discovery announced on Monday that it would split into two public companies by next year, carving off its TV network operations from its streaming service. The move to spin off one company devoted to streaming and a second devoted to traditional television comes as the company struggles with a decline in overall business. The organisation said the new Streaming & Studios group would include Warner Bros. Television, Warner Bros. Motion Picture Group, DC Studios, HBO and HBO Max as well as their film and television libraries. The Global Networks company will include CNN, TNT Sports, Discovery+ and other digital products. Shares in the company jumped more than 9% ahead of the market opening. Current Warner Bros. Discovery CEO David Zaslav will continue as the head of Streaming & Studios, while the company's chief financial officer Gunnar Wiedenfels will become CEO of Global Networks. Both executives will continue in their current positions until the company separates. 'By operating as two distinct and optimised companies in the future, we are empowering these iconic brands with the sharper focus and strategic flexibility they need to compete most effectively in today's evolving media landscape,' Zaslav said in a statement. The US media giant said the split would unlock value for shareholders and create opportunities for both businesses. The split still needs final approval from the company's board but is expected to be completed by the middle of next year. Warner Bros. Discovery was created only three years ago after a merger between Warner Media and Discovery.
Fashion Network
4 hours ago
- Fashion Network
L'Oreal expands dermatological skincare portfolio with Medik8 deal
L'Oreal will acquire British skincare brand Medik8, Britain-based private equity firm Inflexion said on Monday, as the French cosmetics giant boosts its offering in the fast-growing dermatological skincare market. Neither party disclosed the size of the deal. Medik8 produces vitamin A-based anti-aging creams and serums. "The partnership with L'Oreal will allow Medik8 to deepen its presence in existing markets and expand globally. As part of the transaction, Inflexion will retain a minority shareholding in Medik8," the private equity firm said in a statement. L'Oreal's dermatological beauty division, which includes major brands like CeraVe, La Roche-Posay and SkinCeuticals, has remained its fastest-growing unit in recent years. The division generated 7 billion euros ($7.99 billion) in revenue last year, marking a growth of nearly 10% compared to the previous year. The business also delivers the highest profit margin among L'Oreal's four divisions. Consumer interest in science-backed products has driven the division's growth, though rising competition has recently slowed that momentum. L'Oreal executives said this year they are pursuing acquisitions to revive slowing growth. The company acquired Korean skincare brand Dr.G in December and also bought a minority stake in Oman-based perfume house Amouage last year. ($1 = 0.8757 euros)
France 24
5 hours ago
- France 24
US, China trade officials meet in London for new round of negotiations
05:54 From the show American and Chinese delegations are meeting in London for a new round of trade talks, with US tariffs and Chinese export restrictions on rare earth minerals at the top of the agenda. Also in this edition: Japan pushes its own trade talks with Washington, and French art lovers protest a construction project near the site of Paul Cezanne's most famous landscapes.
